Core Insights - The Nasdaq Biotechnology ETF (513290) experienced a net financing purchase of 2.31 million yuan on August 13, 2025, with a financing balance of 39.90 million yuan, marking a continuous net purchase over the last three trading days totaling 5.67 million yuan [1][2][3] Financing Activity Summary - On August 13, 2025, the net financing purchase was 2.31 million yuan, with a financing balance of 39.90 million yuan, reflecting a 6.15% increase from the previous day [2][3][4] - The financing balance increased by 231,280 yuan on August 13, 2025, compared to a smaller increase of 72,900 yuan on August 12, 2025 [4] - Over the last 20 trading days, there were 13 days with net financing purchases, indicating a positive trend in investor sentiment towards the ETF [1] Historical Financing Data - The financing balance on August 12, 2025, was 37.59 million yuan, which increased from 37.51 million yuan on August 11, 2025 [2][4] - The financing balance had previously decreased significantly on August 8, 2025, by 7.49 million yuan, indicating volatility in investor activity [4]
纳指生物科技ETF：8月13日融资净买入231.28万元，连续3日累计净买入566.9万元
Sou Hu Cai Jing·2025-08-14 02:43